Chai Discovery’s $400m raise triples its value to $3.8bn in seven months. It is the latest sign that AI drug discovery has moved from promise to deployment. AI drug discovery just minted another fast-rising star. Chai Discovery has raised a $400m Series C that values the San Francisco startup at $3.8bn, the company said. That […]This story continues at The Next Web